Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences Group (SLS) Total Current Liabilities: 2011-2023

Historic Total Current Liabilities for SELLAS Life Sciences Group (SLS) over the last 7 years, with Dec 2023 value amounting to $13.7 million.

  • SELLAS Life Sciences Group's Total Current Liabilities fell 9.56% to $10.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was $10.6 million, marking a year-over-year decrease of 9.56%. This contributed to the annual value of $13.7 million for FY2023, which is 11.47% down from last year.
  • Per SELLAS Life Sciences Group's latest filing, its Total Current Liabilities stood at $13.7 million for FY2023, which was down 11.47% from $15.5 million recorded in FY2022.
  • SELLAS Life Sciences Group's 5-year Total Current Liabilities high stood at $15.5 million for FY2022, and its period low was $5.0 million during FY2021.
  • For the 3-year period, SELLAS Life Sciences Group's Total Current Liabilities averaged around $11.4 million, with its median value being $13.7 million (2023).
  • Its Total Current Liabilities has fluctuated over the past 5 years, first plummeted by 59.61% in 2021, then soared by 211.42% in 2022.
  • Over the past 5 years, SELLAS Life Sciences Group's Total Current Liabilities (Yearly) stood at $5.3 million in 2019, then spiked by 133.19% to $12.3 million in 2020, then crashed by 59.61% to $5.0 million in 2021, then soared by 211.42% to $15.5 million in 2022, then declined by 11.47% to $13.7 million in 2023.